News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,405 Results
Type
Article (2534)
Company Profile (9)
Press Release (70862)
Section
Business (33905)
Career Advice (60)
Deals (4882)
Drug Delivery (7)
Drug Development (9098)
Employer Resources (12)
FDA (1625)
Job Trends (2183)
News (47260)
Policy (2660)
Tag
Academia (168)
Accelerated approval (2)
Adcomms (2)
Allergies (8)
Alliances (2694)
ALS (10)
Alzheimer's disease (182)
Antibody-drug conjugate (ADC) (9)
Approvals (1652)
Artificial intelligence (16)
Autoimmune disease (4)
Automation (1)
Bankruptcy (18)
Best Places to Work (2054)
Biosimilars (4)
Biotechnology (7)
Bladder cancer (21)
Brain cancer (1)
Breast cancer (61)
Cancer (375)
Cardiovascular disease (27)
Career advice (55)
Career pathing (1)
CAR-T (15)
Cell therapy (44)
Cervical cancer (6)
Clinical research (8061)
Collaboration (50)
Compensation (35)
COVID-19 (234)
CRISPR (3)
C-suite (6)
Cystic fibrosis (12)
Data (438)
Depression (3)
Diabetes (40)
Diagnostics (847)
Digital health (4)
Diversity, equity & inclusion (3)
Drug discovery (12)
Drug pricing (6)
Drug shortages (2)
Duchenne muscular dystrophy (13)
Earnings (30073)
Editorial (4)
Employer resources (10)
Events (7815)
Executive appointments (24)
FDA (1871)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (44)
Gene editing (5)
Generative AI (2)
Gene therapy (28)
GLP-1 (90)
Government (365)
Grass and pollen (1)
Guidances (113)
Healthcare (2414)
IgA nephropathy (11)
Immunology and inflammation (15)
Indications (6)
Infectious disease (257)
Inflammatory bowel disease (6)
Inflation Reduction Act (1)
Influenza (10)
Intellectual property (2)
Interviews (11)
IPO (3614)
IRA (3)
Job creations (242)
Job search strategy (49)
Kidney cancer (1)
Labor market (8)
Layoffs (29)
Legal (387)
Liver cancer (8)
Lung cancer (63)
Lymphoma (41)
Machine learning (2)
Management (4)
Manufacturing (18)
MASH (11)
Medical device (1737)
Medtech (1737)
Mergers & acquisitions (1320)
Metabolic disorders (101)
Multiple sclerosis (15)
NASH (2)
Neurodegenerative disease (12)
Neuropsychiatric disorders (2)
Neuroscience (243)
NextGen: Class of 2025 (579)
Non-profit (277)
Now hiring (2)
Obesity (47)
Opinion (10)
Ovarian cancer (10)
Pain (10)
Pancreatic cancer (4)
Parkinson's disease (12)
Partnered (2)
Patents (14)
Patient recruitment (8)
Peanut (5)
People (2135)
Pharmaceutical (2)
Pharmacy benefit managers (2)
Phase I (1818)
Phase II (3251)
Phase III (3489)
Pipeline (618)
Policy (6)
Postmarket research (350)
Preclinical (612)
Press Release (5)
Prostate cancer (20)
Psychedelics (1)
Radiopharmaceuticals (24)
Rare diseases (44)
Real estate (312)
Recruiting (4)
Regulatory (2147)
Reports (14)
Research institute (156)
Resumes & cover letters (2)
RSV (12)
Schizophrenia (9)
Series A (8)
Series B (7)
Sickle cell disease (8)
Special edition (4)
Spinal muscular atrophy (9)
Startups (157)
Stomach cancer (2)
Supply chain (2)
Tariffs (2)
The Weekly (1)
Vaccines (71)
Venture capitalists (4)
Weight loss (29)
Women's health (2)
Worklife (4)
Date
Today (31)
Last 7 days (280)
Last 30 days (573)
Last 365 days (5025)
2025 (1889)
2024 (5417)
2023 (6443)
2022 (7563)
2021 (7349)
2020 (6925)
2019 (5119)
2018 (3873)
2017 (3288)
2016 (2786)
2015 (3521)
2014 (2472)
2013 (1620)
2012 (1738)
2011 (2245)
2010 (1824)
Location
Africa (53)
Alabama (5)
Alaska (2)
Arizona (9)
Arkansas (1)
Asia (4520)
Australia (673)
California (928)
Canada (277)
China (50)
Colorado (45)
Connecticut (62)
Delaware (45)
Europe (10375)
Florida (167)
Georgia (43)
Idaho (3)
Illinois (51)
India (4)
Indiana (64)
Japan (35)
Kansas (11)
Kentucky (2)
Louisiana (4)
Maine (18)
Maryland (138)
Massachusetts (671)
Michigan (38)
Minnesota (56)
Mississippi (1)
Missouri (13)
Montana (4)
Nevada (8)
New Hampshire (11)
New Jersey (354)
New Mexico (1)
New York (286)
North Carolina (110)
Northern California (453)
Ohio (22)
Oregon (3)
Pennsylvania (230)
South America (106)
South Carolina (1)
Southern California (389)
Tennessee (9)
Texas (103)
United States (3611)
Utah (68)
Virginia (15)
Washington D.C. (5)
Washington State (99)
Wisconsin (7)
73,405 Results for "38".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38
March 10, 2025
·
6 min read
Press Releases
Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer Research (AACR) Annual Meeting
April 28, 2025
·
8 min read
Press Releases
Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma
April 28, 2025
·
5 min read
Press Releases
Allogeneic Cell Therapy Market Size to Hit USD 4,677.38 Million by 203
February 26, 2025
·
1 min read
Press Releases
Cell Culture Market Size Projected to Climb USD 60.38 Billion by 203
February 12, 2025
·
1 min read
Press Releases
Atea Pharmaceuticals Announces Presentation of Bemnifosbuvir Preclinical Data at the 38th International Conference on Antiviral Research (ICAR) 2025
March 19, 2025
·
7 min read
Press Releases
Can-Fite Partner Vetbiolix Accelerate Piclidenoson Development with Advanced Clinical Trial for Canine Osteoarthritis in a $3.8 Billion Market
March 21, 2025
·
7 min read
Biotech Bay
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion.
June 21, 2024
·
3 min read
Press Releases
CARsgen’s Allogeneic CD38 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial
January 20, 2025
·
3 min read
Press Releases
Press Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant
January 31, 2025
·
7 min read
1 of 7,341
Next
